After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »
Home »
Aprepitant APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What
Continue reading »
Emend IV
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EMEND® IV Fosaprepitant dimeglumine Consumer Medicine Information
Continue reading »
Researchers identify genetic factors associated with hand-foot syndrome in chemotherapy with capecitabine
Capecitabine is a chemotherapy drug used for breast and colorectal cancer. It can extend survival rate by nearly 10%. However,
Continue reading »
What’s old is new again: Researchers repurpose classic chemotherapy drug to overcome cancer therapy resistance
Drug resistance is a major obstacle in cancer treatment—leading to relapse for many patients. In a new study, published online
Continue reading »
Intratumoral heterogeneity may be responsible for chemotherapy resistance in patients with small cell lung cancer
Small cell lung cancer (SCLC) accounts for 14% of all lung cancers and is often rapidly resistant to chemotherapy, resulting
Continue reading »
Victoria Derbyshire health: Broadcaster speaks on breast cancer diagnosis and early signs
Choosing to have a career in the spotlight often blurs the lines between a person’s public and private persona. BBC2
Continue reading »
Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer
A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated
Continue reading »
Cancer FAQ – The seven most important questions and answers
About four million Germans are suffering in their lives already to cancer (as of 2017). For 2018, the cancer information
Continue reading »